Article Information
History
- September 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Rana Abdelnabi1,2,
- Dirk Jochmans1,
- Kim Donckers1,
- Bettina Trüeb3,
- Nadine Ebert3,
- Birgit Weynand4,
- Volker Thiel3 and
- Johan Neyts1,2,5,*
- 1KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium
- 2The VirusBank, BioIncubator 4, Gaston Geenslaan, B-3000 Leuven, Belgium
- 3Institute of Virology and Immunology, University of Bern, 3012, Bern, Switzerland; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland
- 4KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, B-3000 Leuven, Belgium; Division of Translational Cell and Tissue Research
- 5Global Virus Network, GVN
- ↵*To whom correspondence may be addressed. Email: johan.neyts{at}kuleuven.be.
Posted September 28, 2022.
Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in Syrian hamsters
